Eu Ddeum Chung

Dr. Eu Ddeum Chung

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
QWQianwei Wang
Qianwei Wang
JCJacqueline Chow
Jacqueline Chow
JHJenny Hong
Jenny Hong
AFAnne C. Ferguson-Smith
Anne C. Ferguson-Smith
CMCarol Moreno
Carol Moreno
SVSusannah Varmuza
Susannah Varmuza
Background: The proximal region of murine Chr 2 has long been known to harbour one or more imprinted genes from classic genetic studies involving reciprocal translocations. No imprinted gene had been identified from this region until our study demonstrated that the PcG gene Sfmbt2 is expressed from the paternally inherited allele in early embryos and extraembryonic tissues. Imprinted genes generally reside in clusters near elements termed Imprinting Control Regions (ICRs), suggesting that Sfmbt2 might represent an anchor for a new imprinted domain. Results: We analyzed allelic expression of approximately 20 genes within a 3.9 Mb domain and found that Sfmbt2 and an overlapping non-coding antisense transcript are the only imprinted genes in this region. These transcripts represent a very narrow imprinted gene locus. We also demonstrate that rat Sfmbt2 is imprinted in extraembryonic tissues. An interesting feature of both mouse and rat Sfmbt2 genes is the presence of a large block of miRNAs in intron 10. Other mammals, including the bovine, lack this block of miRNAs. Consistent with this association, we show that human and bovine Sfmbt2 are biallelic. Other evidence indicates that pig Sfmbt2 is also not imprinted. Further strengthening the argument for recent evolution of Sfmbt2 is our demonstration that a more distant muroid rodent, Peromyscus also lacks imprinting and the block of miRNAs. Conclusions: These observations are consistent with the hypothesis that the block of miRNAs are driving imprinting at this locus. Our results are discussed in the context of ncRNAs at other imprinted loci. Accession numbers for Peromyscus cDNA and intron 10 genomic DNA are [Genbank:HQ416417 and Genbank:HQ416418], respectively.

14 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ECEu Ddeum Chung
Eu Ddeum Chung
DGDeena M. A. Gendoo
Deena M. A. Gendoo
RGRonak Ghanbari-Azarnier
Ronak Ghanbari-Azarnier
JLJeff C. Liu
Jeff C. Liu
ZJZhe Jiang
Zhe Jiang
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
Pineoblastoma is a rare pediatric cancer induced by germline mutations in the tumor suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor prognosis. Here we report that inactivation of Rb plus p53 via a WAP-Cre transgene, commonly used to target the mammary gland during pregnancy, induces metastatic pineoblastoma resembling the human disease with 100% penetrance. A stabilizing mutation rather than deletion of p53 accelerates metastatic dissemination. Deletion of Dicer1 plus p53 via WAP-Cre also predisposes to pineoblastoma, albeit with lower penetrance. In silico analysis predicts tricyclic antidepressants such as nortriptyline as potential therapeutics for both pineoblastoma models. Nortriptyline disrupts the lysosome, leading to accumulation of non-functional autophagosome, cathepsin B release and pineoblastoma cell death. Nortriptyline further synergizes with the antineoplastic drug gemcitabine to effectively suppress pineoblastoma in our preclinical models, offering new modality for this lethal childhood malignancy.

13 January 2022 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
HLHuiqin Li
Huiqin Li
SSStephanie A Schroer
Stephanie A Schroer
VVVeronique Voisin
Veronique Voisin
YJYoungJun Ju
YoungJun Ju
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

18 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
YJYoungJun Ju
YoungJun Ju
AAAmjad Ali
Amjad Ali
ECEu Ddeum Chung
Eu Ddeum Chung
PSPatryk Skowron
Patryk Skowron
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
Metastatic breast-cancer is a major cause of death in women worldwide, yet the relationship between oncogenic drivers that promote metastatic versus primary cancer is still contentious. To elucidate this relationship in treatment-naive animals, we hereby describe mammary-specific transposon-mutagenesis screens in female mice together with loss-of-function Rb, which is frequently inactivated in breast-cancer. We report gene-centric common insertion-sites (gCIS) that are enriched in primary-tumors, in metastases or shared by both compartments. Shared-gCIS comprise a major MET-RAS network, whereas metastasis-gCIS form three additional hubs: Rho-signaling, Ubiquitination and RNA-processing. Pathway analysis of four clinical cohorts with paired primary-tumors and metastases reveals similar organization in human breast-cancer with subtype-specific shared-drivers (e.g. RB1-loss, TP53-loss, high MET, RAS, ER), primary-enriched (EGFR, TGFβ and STAT3) and metastasis-enriched (RHO, PI3K) oncogenic signaling. Inhibitors of RB1-deficiency or MET plus RHO-signaling cooperate to block cell migration and drive tumor cell-death. Thus, targeting shared- and metastasis- but not primary-enriched derivers offers a rational avenue to prevent metastatic breast-cancer.

20 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
ZJZhe Jiang
Zhe Jiang
MAMichelle Sofia Allkanjari
Michelle Sofia Allkanjari
ECEu Ddeum Chung
Eu Ddeum Chung
HTHanna Tran
Hanna Tran
RARonak Ghanbari Azarnier
Ronak Ghanbari Azarnier
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
Pineoblastoma (PB) is a rare yet lethal pediatric brain cancer of the pineal gland, a small endocrine organ that secretes melatonin to regulate the circadian rhythm. For PB patients ≤5 years of age, the overall survival rate is approximately 15%; metastatic PB is incurable. Standard treatment, including surgical resection, radiation, and systemic chemotherapy, improves survival but compromises neurocognitive function. A better understanding of the disease and the generation of preclinical models may enable re-evaluation of previous clinical trials, development of precision therapeutic strategies and improve patient outcome. Over the past 5 years, PB has been recognized to include several major subtypes driven by (i) loss of microRNA processing factors DICER and DROSHA characterized by a relatively good prognosis; (ii) loss of the retinoblastoma tumor suppressor RB1; and (iii) amplification or induction of the cMYC protooncogene, with the latter two subtypes exhibiting exceedingly poor prognosis. Recently, mouse models for the major PB subtypes (RB1-, DICER1- and DROSHA-) except MYC- have been established. This progress, including better understanding of the disease, cell of origin, tumor progression, role of autophagy, and targetable vulnerabilities, holds promise for novel therapeutic strategies to combat each subtype of this lethal childhood malignancy.

1 October 2020 in Data in Brief
Verified
Journal Article
Open access
ECEu Ddeum Chung
Eu Ddeum Chung
Eldad ZacksenhausEldad Zacksenhaus
Eldad Zacksenhaus
Methylation profiling is widely used to study tumor biology and perform cluster analysis, particularly in brain cancer research where tissue biopsies are scarce. We have recently reported on the development of novel mouse models for germ line mutations in pineoblastoma (Nature Communications, 2020). Here, we present unpublished methylation profiling of 8 Rb-deleted/p53-deleted pineoblastoma from our mouse model as well as 3 normal cerebellum tissues as control. The primary dataset can be accessed via SRA (PRJNA638504). These methylation data can be used to perform inter- and intra-species comparisons with other brain cancers as well as with specific subtypes of pineoblastoma, and to investigate potential epigenetic mechanisms and pathways underlying Rb-deficient pineoblastoma-genesis..